Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Laboratoires Thea, 12 rue Louis Blériot, Z.I.du Brézet, 63017 Clermont-Ferrand Cedex 2, France
LIQUIVISC 2.5 mg/g, eye gel.
| Pharmaceutical Form |
|---|
|
Eye gel. Slightly yellow and opalescent gel. |
Carbomer 974P 2.5 mg/g.
Excipient with known effect: benzalkonium chloride (0.06 mg/g).
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Carbomer |
Polyacrylic acid is a hydrophilic, high molecular weight polymer of carboxyvinylic acid. The gel forms a transparent lubricating and moistening film on the surface of the eye. The preparation has a pH similar to that found in the normal tear film and is slightly hypotonic with respect to tears. Polyacrylic acid relieves the symptoms of irritation linked with dry eye syndromes and protects the cornea against drying out. |
| List of Excipients |
|---|
|
Benzalkonium chloride |
10 g in 10 m1 bottle (PE) with dropper (PE).
Laboratoires Thea, 12 rue Louis Blériot, Z.I.du Brézet, 63017 Clermont-Ferrand Cedex 2, France
PL 20162/0009
10/06/2008
| Drug | Countries | |
|---|---|---|
| LIQUIVISC | Ireland, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
